ReviewCurrent diabetes reports2019

Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.

Paul D RosenblitPubMed ↗Publisher ↗

No numbers read from the abstract.